Craig Webster
Analyst · H.C. Wainwright. Please go ahead
Thank you, Zack, and thank you, everyone for tuning in. I will spend the next few minutes discussing our Q3 2023 financial results. Please turn to Slide 12, and I will summarize the main line items from our Q3 P&L. We recorded a really solid quarter with Q3 revenue of $80.1 million, an increase of 107% from $38.6 million in Q3 2022. This growth was driven primarily by strong sales demand in both our European and Asia Pacific markets for commercial vehicles, as OEMs continue to increase their vehicle rounds. On a year-to-date basis, revenue was $202 million, up 45% from $139.7 million in the prior year 9-month period. Our gross margin improved to 22.3% in Q3 2023 compared to 5.2% in Q3 2022. After adjusting for noncash settled share-based compensation expense and cost of sales, adjusted gross margin increased to 24.2% in Q3 2023 compared to 10.2% in Q3 2022. That's a 14 percentage point improvement. With the continuous yield and utilization improvements on the Phase 3.1 line, we expect to maintain and possibly improve these margin levels. Operating expenses were $44.7 million in Q3 2023 compared to $39.6 million in Q3 2022. On a year-to-date basis, operating expenses were $119.9 million, a decrease of 10% from $133.4 million in the prior year 9-month period. After adjusting for noncash SBC expense and SG&A, our adjusted operating expenses in Q3 2023 were $30.3 million, compared to $22.3 million in Q3 2022, an increase of $8 million. This is mainly due to increasing headcount costs and extracting battery specific expertise as we expand our U.S business continue [ph] ramping into the next year. Adjusted operating expenses year-to-date was $72.8 million compared to $75.1 million in the prior year 9-month period. On a year-to-date basis, this reduction in non-GAAP operating expense was mainly due to higher share-based compensation expense in the prior year 9-month period. GAAP net loss was $26.2 million in Q3 2023 compared to a net loss of $36.5 million in Q3 2022. After adjusting for noncash SBC expense, and changes in fair value of our warrant liability, adjusted net loss was $10.3 million in Q3 2023, compared to an adjusted net loss of $17.4 million in Q3 2022. On a year-to-date basis, adjusted net loss was $30.2 million, compared to an adjusted net loss of $61.4 million in the prior year 9-month period. You're starting to see that as we scale our business, we are making significant progress in narrowing our losses, and expect this trend to continue in Q4 and beyond. The impact of these adjustments is shown in 5/13 and reconciliations of non-GAAP metrics to the most comparable GAAP metrics are included in the tables at the end of our earnings press release. Slide 14 showed the geographic breakdown of our revenue for Q3 2023 compared to the prior year period. As you can see, our European business showed outstanding 455% year-over-year increase and accounts for 24% of our revenue, up from just 9% a year ago as key customers begin their vehicle rounds. We continue to expect substantial growth in our India revenues, especially for the 53.5 amp hour cell with much of this already in backlog. As Zach mentioned, we have a couple of multiyear commercial vehicle nominations that would further add to our backlog position in Q4. When we add the important contributions from China and Asia Pacific customers, our overall commercial vehicle revenues have grown 45% year-to-date versus 2022. On the U.S side, revenues are behind where we wanted them to be. Deliveries on projects have been pushed outside. We will begin deliveries in Q4 and they should then make a meaningful contribution to overall 2024 revenues. Turning to Slide 15, our expansion in gross margin in Q4 is a crucial proof point in the maturity of our operations and the growing contribution from the commercial introduction of our new 53.5 amp hour cell. We expect to see further positive impacts across margin as Huzhou Phase 3.1 approaches full utilization in Q4, and on Clarksville Phase 1A start qualify deliveries from Q2 of next year. The backlog number of $678.7 million with over 84% of this for the 53.5 amp hour cell gives us good visibility into the utilization rates for our capacity expansions. Around 65% of the backlog is booked for 2024, mostly for customers in Europe and the U.S. And as Mr. Wu mentioned, we now need to launch a flexible Phase 3.2 line in Huzhou to bring on more capacity to meet demand for 48 amp hour and 53.5 amp hour cells. As you know, our golden rule is that we only add capacity if supported by demand. This new line is situated in the same building as the Phase 3.1 line, which was sized to support a total of 12 gigawatt hours. The lead time to add a new Phase 3.2 line will be around 4 to 6 months, with a majority of the investment being in additional production equipment. Net cash used in operating activities during the quarter was $29.3 million, which was primarily due to operating loss and working capital. Negative free cash flow in the quarter of $89.3 million resulted from this net operating cash outflow as well as our capital investment program. The majority of this capital expenditure in Q3 was to fund our capacity expansion in Clarksville, which totaled $38.3 million. We also have capital expenditures totaling $21.6 million relating to improvements to our existing facilities and ongoing R&D projects. Looking ahead, we estimate that full year capital expenditures will remain in the range of $180 million to $210 million and will primarily be used for the Clarksville Phase 1A capacity expansion. Turning to Slide 16, we detail the financial resilience of Microvast. Our total debt outstanding of $99.5 million is relatively modest. And you can see that the maturity profile requires only 5 million to be repaid in the fourth quarter. Looking further out, total debt repayments of to 31 December 2025 are a very manageable $40.2 million. All of this debt is for our China operations, and none of it has any recourse to our U.S holding structure or assets. We have approximately $70 million available to draw down in order to continue expansion and growth at our Huzhou facility. Part of its being used for the estimated $35 million investment in the Phase 3.2 expansion. This incremental investment in a flexible automated line allows us to respond to both demand for the 53.5 amp hour cell that will exceed Phase 3.1 capacity, and also to deliver 48 amp power cells for the hydrogen fuel cell market. Turning to the U.S operations. These currently remain free of leverage, and we continue to make solid progress on a project at financing which is to be secured by the Phase 1A expansion. We anticipate that facility to be in place during Q4. With that, I will turn it back over to Mr. Wu to review our outlook.